Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer
Conditions: Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Interventions: Drug: Anlotinib Hydrochloride Capsule and Penpulimab Sponsors: Peking Union Medical College Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hospitals | Research | Study | Thyroid | Thyroid Cancer